Transdermal delivery of desmopressin using a coated microneedle array patch system

Journal of Controlled Release

Volumn 97, Issue 3, 2004, Pages 503-511

  Cormier, Michel ^a   Johnson, Bonny ^a   Ameri, Mahmoud ^a   Nyam, Kofi ^a   Libiran, Luz ^a   Zhang, Dee Dee ^a   Daddona, Pete ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Coated microneedle array; Desmopressin; Hairless guinea pig; Pharmacokinetics; Transdermal delivery

Indexed keywords

COATINGS; HORMONES; POLYPEPTIDES; REACTION KINETICS;

ORAL ADMINISTRATION; PEPTIDE HORMONES;

DRUG PRODUCTS;

DESMOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERABILITY; FEASIBILITY STUDY; FEMALE; GUINEA PIG; HAIR; IMMUNOREACTIVITY; MALE; MATERIAL COATING; MEDICAL TECHNOLOGY; NEEDLE; NONHUMAN; PRIORITY JOURNAL; SKIN; SOLID; SURFACE PROPERTY; TIME;

ADMINISTRATION, CUTANEOUS; ANIMALS; DEAMINO ARGININE VASOPRESSIN; DRUG DELIVERY SYSTEMS; FEMALE; GUINEA PIGS; MALE; MICROINJECTIONS;

EID: 3042556333     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.04.003     Document Type: Article

References (33)

1. Fjellestad-Paulsen A., Hoglund P., Lundin S., Paulsen O. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin. Endocrinol. (Oxf.). 38(2):1993;177-182
2. Williams A.C., Barry B.W. Skin absorption enhancers. Crit. Rev. Ther. Drug Carr. Syst. 9:1992;305-353
3. Hsu L.R., Tsai Y.H., Huang Y.B. The effect of pretreatment by penetration enhancers on the in vivo percutaneous absorption of piroxicam from its gel form in rabbits. Int. J. Pharm. 71:1991;193-200
4. Xu P., Chien Y.W. Enhanced skin permeability for transdermal drug delivery: physiopathological and physicochemical considerations. Crit. Rev. Ther. Drug Carr. Syst. 8:1991;211-236
5. Mitragotri S., Farrell J., Tang H., Terahara T., Kost J., Langer R. Determination of threshold energy dose or ultrasound-induced transdermal drug transport. J. Control. Release. 63:2000;41-52
6. Gupta S.K., Sathyan G., Phipps B., Klausner M., Southam M. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. J. Pharm. Sci. 88:1999;835-841
7. Haak R.H., Gupta S.K. Pulsatile drug delivery from electrotransport therapeutic systems. Gurny R., Junginger H.E., Pappas N.A. Pulsatile Drug Delivery. Current Applications and Future Trends. 1989;99-112 Wissenschaftliche Verlagsgesellschaft, Stuttgart
8. Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science. 269:1995;850-853
9. Nakakura M., Kato Y., Ito K. Safe and efficient transdermal delivery of desmopressin acetate by iontophoresis in rats. Biol. Pharm. Bull. 21(3):1998;268-271
10. Nakakura M., Kato Y., Ito K. Prolongation of antidiuretic response to desmopressin acetate by iontophoretic transdermal delivery in rats. Biol. Pharm. Bull. 20(5):1997;537-540
11. Svedman P., Lundin S., Svedmanm C. Administration of antidiuretic peptide (DDAVP) by way of suction de-epithelialised skin. Lancet. 337(8756):1991;1506- 1509
12. Lundin S., Svedman P., Hoglund P., Jonsson K., Broeders A., Melin P. Absorption of an oxytocin antagonist (antocin) and a vasopressin analogue (DDAVP) through a standardized skin erosion in volunteers. Pharm. Res. 12(12):1995;2024-2029
13. 14C]SDZ ENA 713, an acetylcholinesterase inhibitor, in mini pigs following oral, intravenous, and dermal administration. Pharm. Res. 15:1998;1614-1620
14. Kompaore F., Dupont C., Marty J.P. In vivo evaluation in man by two noninvasive methods of stratum corneum barrier function after physical and chemical modifications. Int. J. Cosmet. Sci. 13:1991;293-302
15. Nelson J.S., McCullough J.L., Glenn T.C., Wright W.H., Liaw L.H., Jacques S.L. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. Invest. Dermatol. 97:1991;874-879
16. Henry S., McAllister D.V., Allen M.T., Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87(8):1998;922-925
17. Lin W.Q., Cormier M., Samiee A., Griffin A., Johnson B., Teng C.L., Hardee G.E., Daddona P.E. Transdermal delivery of oligonucleotides with microprojection patch (Macroflux®) technology. Pharm. Res. 18:2001;1789-1793
18. Matriano J., Cormier M., Johnson B., Young W., Buttery M., Nyam K., Daddona P.E. Macroflux® microprojection array patch technology: a new and efficient approach for intracutaneous immunization. Pharm. Res. 19:2002;63-70
19. Cormier M., Daddona P.E. Macroflux® technology for transdermal delivery of therapeutic proteins and vaccines. Rathbone M.J., Hadgraft J., Roberts M.S. Modified Release Drug Delivery Systems. 2002;589-598 Marcel Dekker, New York
20. Suekt H., Gammal C., Kudoh K., Kligman A.M. Hairless guinea pig skin: anatomical basis for studies of cutaneous biology. Eur. J. Dermatol. 10:2000;357-364
21. Kumar S., Char H., Patel S., Piemontese D., Iqbal K., Malick A.W., Neugroschel E., Behl C.R. Effect of iontophoresis on in vitro skin permeation of an analogue of growth hormone releasing factor in the hairless guinea pig model. J. Pharm. Sci. 81:1992;635-639
22. Moon K.C., Webster R.C., Maibach H.I. Diseased skin models in the hairless guinea pig skin: in vivo percutaneous absorption. Dermatologica. 180:1990;8-12
23. Fullerton A., Serup J. Topical D-vitamins: multiparametric comparison of the irritant potential of calcipotriol, calcitriol in a hairless guinea pig model. Contact Dermatitis. 36:1997;184-190
24. Brantley S.K., Davidson S.F., Dasm S.K. A dose-related curve of wound tensile strength following ultraviolet irradiation in the hairless guinea pig. Am. J. Med. Sci. 302:1991;75-81
25. M. Cormier, A.P. Neukermans, B. Block, F.T. Theeuwes, A. Amkraut, A device for enhancing transdermal agent delivery or sampling, EP0914178B1, 2003.
26. J.C. Trautman, C.T. Wright, M. Cormier, Method and apparatus for coating skin piercing microneedles, US Patent Application 0132054, 2002.
27. J.C. Trautman, R.L. Keenan, Microprotrusion member retainer for impact applicator, US Patent Application 0091357, 2002.
28. J.C. Trautman, R.L. Keenan, A.P. Samiee, W.Q. Lin, M. Cormier, J.A. Matriano, P.E. Daddona, Apparatus and method for piercing skin with microprotrusions, US Patent Application 0123675, 2002.
29. Kahns A.H., Moss J., Bundgaard H. Human skin permeability studies of desmopressin and some prodrug derivatives. Acta Pharm. Nord. 4(3):1992;187-188
30. Stocker J.A. Comparison of multiple puncture tuberculin test with purified protein derivative. Am. Rev. Respir. Dis. 96:1967;1067-1068
31. G. Widera, B. Johnson, P. Daddona, M. Cormier, Intracutaneous immunization through microneedle array technology: effect of dose and depth of delivery, in preparation.
32. Hjalmas K., Bengtsson B. Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe. Clin. Pediatr. (Phila.) Spec. No. 1993;19-24
33. G. Sathyan, S. Gupta, M. Ameri, P. Daddona, Transdermal delivery of desmopressin in humans using coated microneedle array, in preparation.